Phenixfin Stock Pattern Recognition Harami Cross Pattern

PFX Stock  USD 41.17  -1.03  -2.44%   
The pattern recognition module provides an execution environment for Harami Cross Pattern recognition and related indicators on Phenixfin. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.

Recognition
The output start index for this execution was eleven with a total number of output elements of fifty. The function generated a total of four valid pattern recognition events for the selected time horizon. The Harami Cross pattern describes Phenixfin bullish reversal trend.

Phenixfin Technical Analysis Modules

Most technical analysis of Phenixfin help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Phenixfin from various momentum indicators to cycle indicators. When you analyze Phenixfin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

The firm seeks to invest in privately negotiated debt and equity securities of small and middle market companies. PhenixFIN Corporation was founded in 2010 and is headquartered in New York, New York. Phenixfin Corp operates under Asset Management classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. The profile for Phenixfin integrates fundamentals, price behavior, and sector exposure. Historical patterns suggest somewhat reduced sensitivity to broader economic swings. Phenixfin has a market cap of 82.27 M, P/E of 71.8, ROE of -1.93%.

Methodology

Unless otherwise specified, financial data for Phenixfin is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Phenixfin (USA Stocks:PFX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Phenixfin is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR. Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Phenixfin may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Learn to be your own money manager

Tracking Phenixfin inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Phenixfin pair trading

Pair trading with Phenixfin can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Phenixfin Pair Trading

Phenixfin Pair Trading Analysis

Using correlated positions as Phenixfin substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track Phenixfin closely enough to maintain equivalent risk and return.
The correlation of Phenixfin with other assets is a key diversification metric. Pairing Phenixfin with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for Phenixfin can be used to frame hedging context. The view can be extended across sectors or other related groups.
Pair CorrelationCorrelation Matching

More Resources for Phenixfin Stock Analysis

A structured review of Phenixfin often starts with core financial statements and trend context. Ratios and trend metrics help frame Phenixfin's operating context. Key reports that frame Phenixfin Stock are listed below:
Phenixfin has a market cap of 82.27 M, operating margin of 68.45%, ROE of -1.93%. Use Your Equity Center to explore allocation context. This includes a position in Phenixfin in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Phenixfin Stock, please use our How to Invest in Phenixfin guide.
Analysis related to Phenixfin should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
 Quarterly Earnings Growth
-0.33
 Earnings Share
-1.54
 Revenue Per Share
12.785
 Quarterly Revenue Growth
0.071
 Return On Assets
0.0319
The market value of Phenixfin is measured differently than book value, which reflects Phenixfin accounting equity. Phenixfin's market capitalization is 82.27 M. A P/B ratio of 0.53 suggests Phenixfin trades near or below book value. Enterprise value stands at 227.89 M. Value and price for Phenixfin are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Phenixfin's intrinsic value and market price are different measures derived from different inputs. For Phenixfin, key inputs include a P/E ratio of 71.8, a P/B ratio of 0.53, a profit margin of -11.98%, and ROE of -1.93%. Market price reflects the current exchange level formed by active bids and offers.